CORC

浏览/检索结果: 共9条,第1-9条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial 期刊论文
HEPATOLOGY, 2017, 卷号: 66
作者:  Wei, Lai;  Xie, Qing;  Hou, Jinlin;  Tang, Hong;  Ning, Qin
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Prevailing genotype distribution and characteristics of human respiratory syncytial virus in northeastern China 期刊论文
JOURNAL OF MEDICAL VIROLOGY, 2017, 卷号: 89, 期号: 2
作者:  Hua, Shucheng;  Zheng, Yuxuan;  Liu, Li;  Wang, Shaohua;  Li, Zhaolong
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Real-world treatment patterns and clinical outcomes of HCV treatment-naive patients in China: an interim analysis from the CCgenos study 期刊论文
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 卷号: 32, 期号: 1
作者:  Wang, Lei;  Rao, Hui-ying;  Li, Hong;  Chen, Hong;  Shang, Jia
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial 期刊论文
HEPATOLOGY, 2017, 卷号: 66
作者:  Wang, Qui-Qiang;  Wei, Lai;  Xie, Qing;  Hou, Jinlin;  Tang, Hong
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Screening HCV genotype-specific epitope peptides based on conservation assessment and B-cell epitope prediction in HCV E2 region 期刊论文
HEPATOLOGY, 2017, 卷号: 66
作者:  Niu, Junqi;  Hua, Rui;  Wang, Shasha;  Qin, Eryun;  Chi, Xiumei
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Screening HCV genotype-specific epitope peptides based on conservation assessment and b-cell epitope prediction in HCV E2 region 期刊论文
Hepatology, 2017
作者:  Hua R., Wang S., Qin E., Chi X., Niu J., Hu Y.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
A phase 3 evaluation of daclatasvir plus asunaprevir in treatmentnaive patients with chronic HCV genotype 1b infection 期刊论文
Hepatology International, 2017, 卷号: 11
作者:  Wei L., Wang F.-S., Zhang M., Jia J., Yakovlev A.A., Xie W., Burnevich E., Niu J., Jung Y.J., Jiang X., Xu M., Chen X., Xie Q., Li J., Hou J., Tang H., Dou X., Gandhi Y., Hu W., McPhee F., Noviello S.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
MAKALU: Twelve-week of treatment with ritonavir-boosted danoprevir pluzs peginterferon and ribavirin produces 96% SVR12 in HCV genotype 1-infected non-cirrhotic chinese patients 期刊论文
Hepatology International, 2017, 卷号: 11
作者:  Zheng S., Hua R., Xie Q., Feng B., Yang Y., Zhang D., Mao Q., Yang Z., Lin M., Zhang L., Tang H., Duan Z., Wang M., Zhuang Y., Yu H., Wang Z., Gao H., Mei L., Luo B., Wu J.J., Niu J., Wei L.
收藏  |  浏览/下载:8/0  |  提交时间:2019/12/05
Safety and efficacy of ledipasvir/sofosbuvir in a genotype 1 HCV infected chinese population: Results from a phase 3, clinical trial 期刊论文
Hepatology, 2017
作者:  Wei L., Xie Q., Hou J., Tang H., Ning Q., Cheng J., Nan Y., Zhang L., Li J., Jiang J., McNabb B.L., Zhang F., Camus G., Mo H., McNally J., Brainard D.M., Subramanian M., Gong G., Mou Z., Wu S., Wang Q
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace